The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-[3-(4-Benzyl-piperidin-1-yl)-propylsulfanyl]-5-nitro-1H-benzoimidazole ID: ALA147200
PubChem CID: 12045497
Max Phase: Preclinical
Molecular Formula: C22H26N4O2S
Molecular Weight: 410.54
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=[N+]([O-])c1ccc2[nH]c(SCCCN3CCC(Cc4ccccc4)CC3)nc2c1
Standard InChI: InChI=1S/C22H26N4O2S/c27-26(28)19-7-8-20-21(16-19)24-22(23-20)29-14-4-11-25-12-9-18(10-13-25)15-17-5-2-1-3-6-17/h1-3,5-8,16,18H,4,9-15H2,(H,23,24)
Standard InChI Key: NUOUVDQBWABUQE-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
9.2875 -6.5792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.7417 -8.1792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.2000 -5.7542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9542 -5.4250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.0917 -6.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3250 -7.4625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5042 -6.0375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5000 -7.4625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6250 -5.3417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.3250 -8.8917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.5667 -8.1792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.3250 -6.0375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7375 -6.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4792 -5.3417 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.6250 -4.5167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9125 -5.7542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4792 -4.1167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2000 -4.5250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7667 -4.5292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3417 -5.7542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2000 -5.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9042 -4.1042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0542 -5.3417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7667 -5.7542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0542 -4.1167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7667 -5.3625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3417 -4.5375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0542 -5.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3417 -5.3625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 6 1 0
3 1 2 0
4 3 1 0
5 1 1 0
6 8 2 0
7 5 2 0
8 5 1 0
9 20 1 0
10 2 1 0
11 2 2 0
12 7 1 0
13 6 1 0
14 3 1 0
15 9 1 0
16 9 1 0
17 18 1 0
18 21 1 0
19 17 1 0
20 23 1 0
21 16 1 0
22 15 1 0
23 24 1 0
24 14 1 0
25 19 2 0
26 19 1 0
27 25 1 0
28 26 2 0
29 28 1 0
7 4 1 0
13 12 2 0
22 18 1 0
27 29 2 0
M CHG 2 2 1 10 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 410.54Molecular Weight (Monoisotopic): 410.1776AlogP: 4.91#Rotatable Bonds: 8Polar Surface Area: 75.06Molecular Species: BASEHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.94CX Basic pKa: 9.73CX LogP: 4.52CX LogD: 3.26Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.25Np Likeness Score: -1.76
References 1. Gregory TF, Wright JL, Wise LD, Meltzer LT, Serpa KA, Konkoy CS, Whittemore ER, Woodward RM.. (2000) Parallel synthesis of a series of subtype-selective NMDA receptor antagonists., 10 (6): [PMID:10741546 ] [10.1016/s0960-894x(00)00035-4 ]